General Information of the Compound
| Compound ID |
CP0366625
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-(4,5-dihydro-1,2-oxazol-3-yloxy)but-2-ynyl-trimethylazanium
Show/Hide
|
||||||||||||||||||
| Synonyms |
BDBM50448377
CHEMBL3121473
GTPL6937
[4-(2-Isoxazoline-3-yloxy)-2-butynyl]trimethylaminium
iperoxo
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C10H17N2O2+
|
||||||||||||||||||
| Molecular Weight |
197.258
|
||||||||||||||||||
| Canonical SMILES |
C[N+](C)(C)CC#CCOC1=NOCC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C10H17N2O2/c1-12(2,3)7-4-5-8-13-10-6-9-14-11-10/h6-9H2,1-3H3/q+1
Show/Hide
|
||||||||||||||||||
| InChIKey |
WXXOCGISBCTWPW-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01310, Muscarinic acetylcholine receptor M1
Clinical Information about the Compound
Drug 1 ( iperoxo )
| Drug Name | iperoxo | ||
|---|---|---|---|